As of November 2025, FTI's trailing twelve months (TTM) EPS stands at $2.27, according to the latest financial reports. In 2024, the company recorded an earnings per share (EPS) of $1.96, which represents an increase compared to its EPS of $0.13 in 2023. FTI reported an EPS of $0.76 for the quarterly report ending on Sep 30, 2025.
For 2024, TechnipFMC's EPS was $1.96, an increase of 1,407.7% from $0.13 in 2023. For the quarter ending Sep 30, 2025, the EPS was $0.76, showing a 18.8% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of September 2025 is $2.27. In 2023, the annual EPS was $0.13, showing an increase of 154.2% from 2022.
Over the last 12 months, TechnipFMC has registered an EPS growth of 18.8% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of 302.8% per year over the past 3 years. A 10-year view shows that FTI has seen an average EPS growth of -7.5% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| SLB Schlumberger Limited | 14 | 6.4% | 32.8% | N/A |
| NOV National Oilwell Varco Inc | 15.01 | -36% | N/A | N/A |
| OIS Oil States International Inc | 16.62 | -190% | N/A | N/A |
| FTI TechnipFMC plc | 18.65 | 1,407.7% | 302.8% | N/A |
| INVX Innovex International Inc. | 30.78 | 18% | N/A | 124% |
| GE General Electric Co | 40.36 | -28.4% | N/A | N/A |
| FET Forum Energy Technologies Inc | N/A | -494.6% | N/A | N/A |
| BOLT Bolt Biotherapeutics Inc | N/A | 9.8% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.